PEN:NYSE
Penumbra Inc
317,55 $
arrow_downward
-0,14%(-0,45) 1D
317,54 $
arrow_downward
-0,00% (-0,0079)bedtimeAfter hours
Closed: 2 қаз., 16:00:04 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
318,37 $
High
318,37 $
Low
316,78 $
Mkt. cap
12,51 млрд
Avg. vol.
352,00 м.
Volume
239,68 м.
P/E ratio
77,99
52-wk high
362,41 $
52-wk low
221,26 $
EPS
4,07 $
Beta
0,70
Shares outstanding
39,39 млн
No. of employees
5 мың
Open
318,37 $
High
318,37 $
Low
316,78 $
Mkt. cap
12,51 млрд
Avg. vol.
352,00 м.
Volume
239,68 м.
P/E ratio
77,99
52-wk high
362,41 $
52-wk low
221,26 $
EPS
4,07 $
Beta
0,70
Shares outstanding
39,39 млн
No. of employees
5 мың
News stories
From web sources and news partners
AD HOC NEWS
·
1 күн бұрын
Boston Scientific keeps Penumbra deal on track as Penumbra stock costs EUR 284.00
Zacks
·
1 күн бұрын
IART vs. PEN: Which Stock Is the Better Value Option?
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc